Abstract
Summary
This study examined musculoskeletal health in amphetamine users, compared with healthy age-matched controls. We show that amphetamine users have reduced bone mass at several skeletal sites and attenuated maximal muscle strength and force development capacity in the lower extremities.
Introduction
Amphetamine use may cause poor bone quality and elevated risk of osteoporosis. The purpose of this study was to investigate whether amphetamine users exhibit reduced regional and whole body bone mineral density (BMD), altered bone metabolism, and how muscle function may relate to the patient groups’ skeletal health.
Methods
We assessed hip, lumbar spine and whole body BMD, and trabecular bone score (TBS) by dual x-ray absorptiometry (DXA), and bone metabolism markers in serum and maximal strength and force development capacity in 36 amphetamine users (25 men, 30 ± 7 years; 11 women 35 ± 10 years) and in 37 healthy controls (23 men, 31 ± 9 years; 14 women, 35 ± 7 years).
Results
Whole body BMD was lower in amphetamine users (8 % in males and 7 % females, p < 0.01), as were BMD at the total hip and sub-regions of the hip (9–11 % in men and 10–11 % in women, p < 0.05). Male users had 4 % lower TBS (p < 0.05) and higher serum level of type 1 collagen amino-terminal propeptide (p < 0.01). This coincided with reduced lower extremity maximal strength of 30 % (males, p < 0.001) and 25 % (females, p < 0.05) and 27 % slower muscular force development in males compared to controls (p < 0.01).
Conclusions
These findings demonstrate that amphetamine users suffer from a generalized reduction in bone mass, which was associated with attenuated maximal muscle strength and force development capacity in the lower extremities.
Similar content being viewed by others
References
Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA (2006) Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. J Subst Abus Treat 31:195–202
Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH (2000) Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci 12:480–484
Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, Okudaira K, Iseki E, Sakai T, Kosaka K (2002) Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 97:809–817
Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M, Methamphetamine Treatment P (2004) Psychiatric symptoms in methamphetamine users. Am J Addict 13:181–190
Flemmen G, Unhjem R, Wang E (2014) High-intensity interval training in patients with substance use disorder. BioMed Res Int 2014:616935
Dolezal BA, Chudzynski J, Storer TW, Abrazado M, Penate J, Mooney L, Dickerson D, Rawson RA, Cooper CB (2013) Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment. J Addict Med 7:122–128
Kemmler W, Bebenek M, von Stengel S, Bauer J (2014) Peak-bone-mass development in young adults: effects of study program related levels of occupational and leisure time physical activity and exercise. A prospective 5-year study. Osteoporos Intl: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA
Tan VP, Macdonald HM, Kim S, Nettlefold L, Gabel L, Ashe MC, McKay HA (2014) Influence of physical activity on bone strength in children and adolescents: a systematic review and narrative synthesis. J Bone Miner Res: Off J Am Soc Bone Miner Res 29:2161–2181
Katsuragawa Y (1999) Effect of methamphetamine abuse on the bone quality of the calcaneus. Forensic Sci Int 101:43–48
Kim EY, Kwon do H, Lee BD, Kim YT, Ahn YB, Yoon KY, Sa SJ, Cho W, Cho SN (2009) Frequency of osteoporosis in 46 men with methamphetamine abuse hospitalized in a national hospital. Forensic Sci Int 188:75–80
Tomita M, Katsuyama H, Watanabe Y, Okuyama T, Fushimi S, Ishikawa T, Nata M, Miyamoto O (2014) Does methamphetamine affect bone metabolism? Toxicology 319:63–68
Rantalainen T, Nikander R, Heinonen A, Multanen J, Hakkinen A, Jamsa T, Kiviranta I, Linnamo V, Komi PV, Sievanen H (2010) Neuromuscular performance and body mass as indices of bone loading in premenopausal and postmenopausal women. Bone 46:964–969
Stengel SV, Kemmler W, Pintag R, Beeskow C, Weineck J, Lauber D, Kalender WA, Engelke K (2005) Power training is more effective than strength training for maintaining bone mineral density in postmenopausal women. J Appl Physiol 99:181–188
Mosti MP, Carlsen T, Aas E, Hoff J, Stunes AK, Syversen U (2014) Maximal strength training improves bone mineral density and neuromuscular performance in young adult women. J Strength Cond Res / Natl Strength Cond Assoc 28:2935–2945
Kato T, Terashima T, Yamashita T, Hatanaka Y, Honda A, Umemura Y (2006) Effect of low-repetition jump training on bone mineral density in young women. J Appl Physiol 100:839–843
Schmidt CJ, Gibb JW (1985) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur J Pharmacol 109:73–80
Burrows KB, Gudelsky G, Yamamoto BK (2000) Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J Pharmacol 398:11–18
Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311:1–7
Kadota T, Kadota K (2004) Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine. Arch Histol Cytol 67:241–251
Cadet JL, Jayanthi S, Deng X (2005) Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Rev Neurotoxicity Res 8:199–206
McLean RR, Shardell MD, Alley DE et al (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol Ser A Biol Med Sci 69:576–583
Ortega FB, Silventoinen K, Tynelius P, Rasmussen F (2012) Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ 345, e7279
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the addiction severity index. J Subst Abus Treat 9:199–213
Briot K, Paternotte S, Kolta S, Eastell R, Reid DM, Felsenberg D, Gluer CC, Roux C (2013) Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone 57:232–236
Briot K, Roux C (2008) Drug-induced osteoporosis: beyond glucocorticoids. Curr Rheumatol Rep 10:102–109
Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A, McCloskey EV, Hans D (2014) Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporosis Found USA 25:2271–2277
Jenkins N, Black M, Paul E, Pasco JA, Kotowicz MA, Schneider HG (2013) Age-related reference intervals for bone turnover markers from an Australian reference population. Bone 55:271–276
Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vazquez I, Cerda D, Ballesta AM, Munoz-Gomez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266–269
Nagata Y, Imanishi Y, Ishii A et al (2011) Evaluation of bone markers in hypophosphatemic rickets/osteomalacia. Endocrine 40:315–317
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501
Colussi-Mas J, Panayi F, Scarna H, Renaud B, Berod A, Lambas-Senas L (2005) Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis. Int J Neuropsychopharmacol 8:569–581
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317
Bonnet N, Benhamou CL, Beaupied H, Laroche N, Vico L, Dolleans E, Courteix D (2007) Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats. J Appl Physiol 102:1502–1509
Bonnet N, Benhamou CL, Brunet-Imbault B, Arlettaz A, Horcajada MN, Richard O, Vico L, Collomp K, Courteix D (2005) Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 37:622–633
Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122:803–815
Aagaard P, Suetta C, Caserotti P, Magnusson SP, Kjaer M (2010) Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports 20:49–64
Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, Roy TA, Hurley BF (1997) Age and gender comparisons of muscle strength in 654 women and men aged 20–93 yr. J Appl Physiol 83:1581–1587
Aagaard P, Simonsen EB, Andersen JL, Magnusson P, Dyhre-Poulsen P (2002) Increased rate of force development and neural drive of human skeletal muscle following resistance training. J Appl Physiol 93:1318–1326
Hvid L, Aagaard P, Justesen L, Bayer ML, Andersen JL, Ortenblad N, Kjaer M, Suetta C (2010) Effects of aging on muscle mechanical function and muscle fiber morphology during short-term immobilization and subsequent retraining. J Appl Physiol 109:1628–1634
Kaptoge S, Dalzell N, Jakes RW, Wareham N, Day NE, Khaw KT, Beck TJ, Loveridge N, Reeve J (2003) Hip section modulus, a measure of bending resistance, is more strongly related to reported physical activity than BMD. Osteoporos Int 14:941–949
Karasik D, Kiel DP (2010) Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46:1226–1237
Judex S, Carlson KJ (2009) Is bone’s response to mechanical signals dominated by gravitational loading? Med Sci Sports Exerc 41:2037–2043
Iizuka K, Machida T, Hirafuji M (2014) Skeletal muscle is an endocrine organ. J Pharmacol Sci 125:125–131
Acknowledgments
The corresponding author was funded by a grant from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU). We thank Stian Kwak for assistance with the blood sample collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Ethics approval
The regional medical ethics committee (REK-nord) approved the study, and it was carried out in accordance with the Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Mosti, M.P., Flemmen, G., Hoff, J. et al. Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment. Osteoporos Int 27, 1003–1010 (2016). https://doi.org/10.1007/s00198-015-3371-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-015-3371-z